Plus-size patients and TRT: Is 'poor care' a systemic problem?

What did @lifewithhanny actually say?

This is less a medical claim video and more a patient experience video. @lifewithhanny describes a string of negative encounters with doctors across about 15 years, most of them involving dismissal tied to her weight. The pattern she describes is specific: whenever she brought a health concern, providers defaulted to "it's just because you're overweight, you need to lose weight." She also describes being denied anxiety medication, being pressured toward GLP-1 drugs she'd never heard of, and being lectured about religion during a physical. The TRT category tag attached to this video doesn't match the content. She never mentions testosterone, hormones, or anything adjacent to TRT. That mismatch matters because it can send people looking for hormone-related information somewhere genuinely unhelpful.

Her core thesis is straightforward: patients deserve doctors who listen, and many don't get that, especially plus-size patients. That's not a fringe position. It's documented in peer-reviewed literature.

Does the science back this up?

Yes, more than most people want to admit. Weight bias in clinical settings is real, well-documented, and has measurable consequences for patient health outcomes. Studies consistently show that patients in larger bodies receive less diagnostic workup and more generic lifestyle advice than their thinner counterparts presenting with identical symptoms.

A 2016 survey published in Obesity Reviews (Alberga et al.) found that medical students and physicians hold strong implicit and explicit anti-fat biases, often comparable to racial bias in magnitude. A 2019 study in Patient Education and Counseling (Phelan et al.) found that patients who perceived weight stigma from their providers were significantly less likely to follow up on care, less likely to disclose symptoms, and more likely to delay future appointments. That last part is important: @lifewithhanny literally says she stopped going to the doctor for years after repeated bad experiences. The research predicts exactly that behavior.

On the anxiety medication piece, her account of being told to "just get over it" aligns with documented undertreatment of anxiety disorders in primary care, particularly in patients from stigmatized groups. That's not a conspiracy. It's a known gap in care delivery.

What did they get wrong (or right)?

She got the core dynamic right. Patients in larger bodies are frequently dismissed in clinical settings, and the consequences include delayed diagnoses, undertreated mental health conditions, and care avoidance. She's not exaggerating a fringe experience. She's describing something with a body of research behind it.

A few things are harder to evaluate. Her account of one provider "messing up" with a medication she was taking (she references "goby," likely Qelbree or possibly Gabi, though it's unclear) is unverifiable from a transcript. She doesn't give enough detail to assess whether that was a genuine clinical error or a misunderstanding, and it wouldn't be fair to draw conclusions either way.

The GLP-1 pressure she describes deserves a closer look. She frames a doctor recommending a GLP-1 medication as suspicious. At the time she describes (around 2022), semaglutide had already received FDA approval for chronic weight management in adults (Wegovy, June 2021). A provider recommending it wasn't doing something rogue. Whether that recommendation was appropriate for her specifically, without a full clinical picture, is unknowable. Her discomfort with an unfamiliar medication being pushed on her without explanation is a legitimate informed consent concern. The problem wasn't the drug. It was the communication.

What should you actually know?

If you've had experiences like hers, you're not alone and you're not being oversensitive. The medical literature is clear that weight bias affects the quality of care patients receive. A 2021 systematic review in Obesity Reviews (Tomiyama et al.) found that weight stigma is associated with increased mortality risk, partly through exactly the care-avoidance pathway @lifewithhanny describes.

Finding a primary care provider who takes your concerns seriously is not a luxury preference. It has real clinical implications. Patients with trusting provider relationships have better medication adherence, better preventive screening rates, and better chronic disease outcomes (Ha & Longnecker, 2010, Medical Principles and Practice).

On GLP-1 medications specifically: they're not something to fear because they're new, and they're not a cure-all to accept without a full conversation about risks, benefits, and alternatives. Any provider worth their license should be able to explain a medication recommendation in plain language before expecting you to agree to it.

One more thing: this video was tagged under TRT. She never mentions testosterone replacement therapy, hormones, or anything related. If you arrived here looking for TRT information, this video isn't a source for that.